 Proactive Investors USA & Canada | Spectrum Pharmaceuticals Announces Outstanding ZEVALIN ... Business Wire (press release) The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) ... Most (80%) fatalities occurred with the first rituximab infusion. SPECTRUM PHARMACEUTICALS, INC. : Spectrum ... New clinical data for ZEVALIN Injection for intravenous use ... |
